Brave New World The Unitary Patent and Unified Patent Court · Many companies likely to use UP...
Transcript of Brave New World The Unitary Patent and Unified Patent Court · Many companies likely to use UP...
Brave New World
The Unitary Patent and Unified Patent Court
Brave New World
The Unitary Patent and Unified Patent Court The Unitary Patent and Unified Patent Court The Unitary Patent and Unified Patent Court
Managing Intellectual Property
International Patent Forum
London, 16 & 17 April 2013
Managing Intellectual Property
International Patent Forum
London, 16 & 17 April 2013
Introduction
Brave New World
Introduction
Brave New World
Gordon Harris
Head of Intellectual Property
Wragge & Co LLP
Gordon Harris
Head of Intellectual Property
Wragge & Co LLP
Brave New World
� Setting the scene
� Planning a new style portfolio
� Litigation strategy – a view from business� Litigation strategy – a view from business
� Litigation strategy – a view from private practice
Gordon Harris, Wragge & Co LLP
Problems with the existing system
� Patents in Europe are expensive to acquire (translation costs),
maintain (renewal fees) and litigate (multi-jurisdictional)
� Different outcomes on the “same” patent
– Validity– Validity
– Infringement
– Remedies – interim and final
– To what extent is this caused by differences in procedural rules?
� Forum shopping
Gordon Harris, Wragge & Co LLP
“Solutions”
� European Patent with Unitary Effect (“Unitary patent”) –
an EP with unitary effect across all participating Member
States
– Costs unknown – national patents/EPs with few national – Costs unknown – national patents/EPs with few national
designations may be cheaper for some
– Does new provision remove or embed variations in national laws
into the system?
Gordon Harris, Wragge & Co LLP
“Solutions”
� Unitary Patent Court
– Decisions effective throughout between 13 and 27 Member States –significant commercial impact on D if patent infringed and P if patent revoked
– Exclusive jurisdiction to hear all infringement/revocation cases for existing and new EPs (including unitary patents)
– Subject to
– right to sue in national courts for EPs (not unitary) for 7 years
– right to opt out of Court jurisdiction (and opt back in) for existing EPs (not unitary) and those applied for the next 7 years
Gordon Harris, Wragge & Co LLP
The Patent Court – some general points
� 3 types of division
– Central – revocation actions and applications for declaration for non-
infringement – a central division in 3 locations – judges from 3 countries
(probably)
– Local (and regional) – infringement – courts may bifurcate infringement
and validity (inherently pro-P?)
– 3 (or 4) judges per case
– “Experienced” local divisions will have 2 judges from 1 country +1 from another –
“local flavour”
– “Inexperienced” local divisions (and regional) will have 3 from different countries
Gordon Harris, Wragge & Co LLP
The Patent Court – some general points
� Patentee may well have multiple choices as to the division
in which to bring infringement proceedings – place of D’s
business or place of infringement (likely to be multiple)
� Court has many powers but little guidance as to how to � Court has many powers but little guidance as to how to
exercise them
� No guidance on Court fees or costs but may well be more
expensive than litigating in any one Member State (other
than UK)
Gordon Harris, Wragge & Co LLP
IntroductionIntroduction
Belinda Gascoyne
IP Law Counsel, UK IP Department Manager
IBM
Belinda Gascoyne
IP Law Counsel, UK IP Department Manager
IBM
The Hype
� According to the European Commission’s FAQs:
� “The single unitary patent option will offer those who wish to protect their invention in Europe huge cost advantages and reduce the administrative burden.and reduce the administrative burden.
� The single jurisdiction for patent matters will have the major advantage compared to today’s situation that, in the future, legal certainty will be enhanced. The risk of multiple parallel court proceedings leading possibly to divergent outcomes will disappear”.
Source: http://ec.europa.eu/internal_market/indprop/patent/faqs/index_en.htm
Belinda Gascoyne, IBM
How to obtain a ‘Unitary’ Patent
� Available via the EPO – apply in the usual way, same patentability requirements
� Elect ‘unitary protection’ at grant stage
– Must have same claims for all Member States
� Post-grant treated as having unitary effect – no national validation process or validation fees required
� Subject to the exclusive jurisdiction of the new Unified Court
� Renewal fees not yet decided
– Will cover costs & be ‘progressive’
– Single fee paid to EPO (50% shared with NPOs)
Belinda Gascoyne, IBM
Translation requirements
� Claims required in 3 EPO languages, as now
� Specification in one other language during transitional period*
– German/French + English
– English + any other EU language– English + any other EU language
*12 yrs max, reviewed after 6 yrs – until decent machine translations available at EPO in all EU languages.
� Compensation (full, not capped) for EU SMEs translating from own language into EPO language (Art 5. Translation Regulation)
� Translation also in case of dispute, and in legal proceedings
Belinda Gascoyne, IBM
What might it cost?
� Level of renewal fees to be set at a level that:
(a) is equivalent to the renewal fee to be paid for the average geographical coverage of current European patents
(b) reflects the renewal rate of current European patents; and
(c) reflects the number of requests for unitary effect.(Article 12(3) REGULATION (EU) No 1257/2012)
� Currently, a European Patent is validated on average in 5 EU Member States.(Source: EC Impact Assessment 30.6.2010)
� Only 8% of EP patents are currently renewed until statutory term (20 yrs).
(Source: Dominique Guellec, Bruno van Pottelsberghe: The Economics of the European Patent System, O.U.P. 2007)
Belinda Gascoyne, IBM
Current geographical coverage of EP patents – at validation
GB, DE, FR - 50%
GB, DE, FR, IT, ES - 40%
13 or more MS - 8%
All 27 EU MS - 2%
(Source: European Commission Impact Assessment 13.4.2011)
Belinda Gascoyne, IBM
If UP renewal fee = ‘5’ renewal fees…
� For the 50% of cases where validation only in DE, FR and GB,
traditional EP (or national) route would be cheaper than UP – 3
renewal fees instead of ‘5’ and no translation of spec required.
� For the 40% of cases validated in DE, FR, GB, IT and ES, normal EP � For the 40% of cases validated in DE, FR, GB, IT and ES, normal EP
route would again be cheaper – UP won’t cover IT or ES, so still need
to translate and will essentially be paying ‘5’+2 renewals.
� For (currently 10% of) cases validated in 13 or more MS – UP route will
probably be cheaper & for all MS MUCH cheaper.
(Based on an analysis by Reddie & Grose)
Belinda Gascoyne, IBM
But…
� Some rumours that renewal fee might be equivalent to
eight or even more national renewal fees
� Once UP elected must pay the full UP renewal fee – cannot
cherry pick countries at later stage to reduce renewal cherry pick countries at later stage to reduce renewal
payments as we do now
Belinda Gascoyne, IBM
The Patent Portfolio of the Future?
� Despite the litigation uncertainty and risk of central
revocation, the UP route will be used.
� Many companies likely to use UP route for at least some
new EP grants. I expect for more than just the 10% of new EP grants. I expect for more than just the 10% of
cases which are currently validated in 13 or more MS.
� Some may start to file more national patent applications
so as to avoid the risk of central revocation and
jurisdiction of the Unified Patent Court.
Belinda Gascoyne, IBM
IntroductionIntroduction
David Rosenberg
Vice-President Corporate IP Policy
GlaxoSmithKline
David Rosenberg
Vice-President Corporate IP Policy
GlaxoSmithKline
The impact of this structure
� National composition of panels plus wide discretion as to how to
exercise powers => local flavour of proceedings?
– Procedural issues – bifurcation, discovery, cross-examination
– Substantive issues e.g. Claim construction, defences– Substantive issues e.g. Claim construction, defences
– Remedies – interim and final
� Significant variability in approaches between different divisions for
many years?
� A trend towards pro-plaintiff bias as courts compete for business?
David Rosenberg, GlaxoSmithKline
So where does this leave the litigation system?
� National patents – sue in national courts
� European (non-unitary) patents – some options
– Don’t opt out
– In 7 year transitional period, sue in national court; or– In 7 year transitional period, sue in national court; or
– Sue in new court (risk pan-European revocation but get pan-European relief)
– Opt out with some/all existing patents and those applied for next 7 years – avoid risk of pan-European revocation – sue in national courts for national relief
– Opt back in if it suits you at the time of infringement and choose division where most likely to win
� Unitary patent – sue in new court
David Rosenberg, GlaxoSmithKline
Advise the patentee
� Filing strategy – national, “ordinary” EP or unitary
– How many countries do you need protection in?
– Can you risk pan-European revocation? If not, unitary unlikely to be suitable
� Opt out strategy for those who select “ordinary” EPs� Opt out strategy for those who select “ordinary” EPs
– If remain in, risk action for pan-European revocation in central division
– If opt out, this risk avoided, and can opt back in to get pan-European relief if it suits at time of infringement
� Litigation strategy
– Multiple options – national courts, choice of divisions in unified court
– Is the risk/reward balance in favour of using national courts or unified court
David Rosenberg, GlaxoSmithKline
Advise the defendant
� Pan-European risks
� Plaintiff has many forum shopping options – you have no such choices and limited options
� National courts and unified court divisions, or some of them, may � National courts and unified court divisions, or some of them, may become more pro-plaintiff to attract/maintain business
� Risks from “non-practising entities” may increase significantly
� Consider revocation/declaration of non-infringement first strike if threat anticipated – in UPC if not opted out, will prevent opt out; in “best” national court if opted out, will (probably) prevent opt in (but only have national effect)
David Rosenberg, GlaxoSmithKline
IntroductionIntroduction
David Barron
Partner
Wragge & Co LLP
David Barron
Partner
Wragge & Co LLP
Litigating under the new regime –existing patents
� Universal view that should opt out EPs
� Maximises flexibility/retains options
� Who will opt in for litigation?
� Uncertainty around costs/speed/quality/appeals
� Short term - reluctance to be guinea pig
� A favourable decision in one jurisdiction typically brings a Defendant to the table. Why risk all?
David Barron, Wragge & Co LLP
Litigating under the new system – the view from private practice
� No lack of information
� Some lack of planning
� Specifically – planning around portfolio strategy:
–– whether to move to nationals or stay with EPs
– or switch to Unitary Patents
– or obtain a combination. If so, what combination?
� Decisions made now will impact on litigation strategy in years to come
David Barron, Wragge & Co LLP
Forum Shopping is Dead – Long Live Forum Shopping!
� Claimant chooses
� Expect differences in speed, quality, pro/anti-patentee/bifurcation
� Interim � Interim remedies/discovery/experts/ tactical moves
� Forum-shopping is inevitable
� Appeal decisions may reduce differences over time, but won’t eliminate forum shopping
David Barron, Wragge & Co LLP
So who/when will the new system be used?
� What sort of claimant?
� Operating what sort of business
model?
� For which sorts of patents?� For which sorts of patents?
� In which local/regional
divisions?
� How long before the system
settles down?
Questions &
Answers
Questions &
AnswersAnswersAnswers
Managing Intellectual Property
International Patent Forum
London, 16 & 17 April 2013
Managing Intellectual Property
International Patent Forum
London, 16 & 17 April 2013